Submitted by Anonymous (not verified) on 28 July 2025 - 16:00
Human medicines European public assessment report (EPAR): Osvyrti, denosumab, Date of authorisation: 26/05/2025, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Osvyrti, denosumab, Date of authorisation: 26/05/2025, Status: Authorised